Publications by authors named "Valdez-Gonzalez A"

Article Synopsis
  • * A cohort of 5143 patients with type 2 diabetes was followed for one year to assess factors predicting the onset of MASLD, with measurements including body weight, blood sugar levels, and liver markers.
  • * Results showed that 28.2% of patients had MASLD initially; while some improved, a significant number retained the condition, indicating that tools like Hepatic Steatosis Index, Lipidic Accumulation Product, and metabolic screening could help identify those at risk.
View Article and Find Full Text PDF

Purpose: The COVID-19 Fear Scale (FCV-19S) allows screening in general population; however, there is no specific instrument in our population for screening in the perinatal period that considers fear related with COVID-19 and offspring well-being. We aimed to validate the FCV-19S modified for application during the perinatal period.

Materials And Methods: Analytical, cross-sectional design.

View Article and Find Full Text PDF

Introduction: The fear of COVID-19 scale (FCV-19S) is used to screen for symptoms of anxiety and depression related to COVID-19 in the general population; it consists of seven questions with Likert-type answers (1-5). Our objective was to validate FCV-19S Spanish version in the Mexican general population.

Material And Methods: Analytical, cross-sectional design.

View Article and Find Full Text PDF

Context: Little is known about the association between haptoglobin level and cardiometabolic traits. A previous genome-wide association study identified rs2000999 in the HP gene as the stronger genetic contributor to serum haptoglobin level in European populations.

Objective And Design: We investigated the association of HP rs2000999 with serum haptoglobin and childhood and adult obesity in up to 540/697 and 592/691 Mexican cases and controls, respectively.

View Article and Find Full Text PDF

Introduction: The prevalence of chronic complications and comorbidities in patients with type 2 diabetes (T2D) has increased worldwide.

Objective: To compare the prevalence of complications and chronic comorbidities in patients with T2D at 36 family medicine units of five chapters of the Mexican Institute of Social Security (IMSS).

Method: Complications (hypoglycemia, diabetic foot, kidney disease, retinopathy, ischemic heart disease, cerebrovascular disease and heart failure) and comorbidities (liver disease, cancer and anemia) were identified according to codes of the International Classification of Diseases, 10 Revision.

View Article and Find Full Text PDF

The effect of pre-treated peat moss on the ability of a sulfate-reducing microbial consortium to remove chromium and lead in solution was evaluated. The most active bacterial community (235.7 mmol H2S/g VSS) was selected from among eight consortia.

View Article and Find Full Text PDF